Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Burris S, Blankenship KM, Donoghoe M, Sherman S, Vernick JS, Case P, Lazzarini Z, Koester S.

Milbank Q. 2004;82(1):125-56. Review.

2.

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.

Hammett TM, Wu Z, Duc TT, Stephens D, Sullivan S, Liu W, Chen Y, Ngu D, Des Jarlais DC.

Addiction. 2008 Jan;103(1):137-45. Epub 2007 Nov 20. Review.

PMID:
18028519
3.

Public health 2: Criminal liability for spreading disease.

Griffith R, Tengnah C.

Br J Community Nurs. 2005 Oct;10(10):475-8. Review.

PMID:
16234745
4.

Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE.

J Urban Health. 2006 Jan;83(1):86-100. Review.

5.

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG.

J Adv Nurs. 2001 Feb;33(3):357-70. Review.

PMID:
11251723
6.

An inappropriate tool: criminal law and HIV in Asia.

Csete J, Dube S.

AIDS. 2010 Sep;24 Suppl 3:S80-5. doi: 10.1097/01.aids.0000390093.53059.b8. Review.

PMID:
20926932
7.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
8.

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use..

Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26. Review.

PMID:
20189638
9.

Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.

Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A; Substance Use Scientific Committee of the HIV Prevention Trials Network..

Curr Opin HIV AIDS. 2012 Jul;7(4):320-5. doi: 10.1097/COH.0b013e32835369ad. Review.

10.

Syringe exchange in Canada: good but not enough to stem the HIV tide.

Hankins CA.

Subst Use Misuse. 1998 Apr;33(5):1129-46. Review.

PMID:
9596380
11.

Challenges facing health professionals caring for HIV-infected drug users.

Inungu J, Beach EM, Skeel R.

AIDS Patient Care STDS. 2003 Jul;17(7):333-43. Review.

PMID:
12952735
12.

Hepatitis C and HIV infections: implications for clinical care in injection drug users.

Sullivan LE, Fiellin DA.

Am J Addict. 2004 Jan-Feb;13(1):1-20. Review.

PMID:
14766434

Supplemental Content

Support Center